Members of the Trust Board
The non-executive and executive directors of the Trust, who together comprise the Trust Board, are listed below.
Peter Hollins, chair
Peter graduated in chemistry from Oxford. In 1973 he joined Imperial Chemical Industries (ICI) where he undertook a series of increasingly senior roles in marketing and then general management.
Following three years in the Netherlands as general manager of ICI Resins BV, he was appointed chief operating officer of EVC in Brussels, a joint venture between ICI and Enichem of Italy, in 1992. He played a key role in the flotation of the company in 1994, before returning to the UK in 1998 as chief executive officer of British Energy where he remained until 2001. From 2001 onwards he held various chairmanships and non-executive directorships. In 2003 he decided to return to an executive role as chief executive of the British Heart Foundation, where he remained in post until retirement in March 2013.
Keith graduated in economics from Cambridge. In 1975 he joined one of the forerunner firms which now comprise PwC, qualifying as a chartered accountant in 1978.
At PwC he undertook a number of roles in audit, consultancy and corporate finance. He was a partner for over 25 years including being the senior partner for many years at the firm's Southampton office.
Since retirement he has taken on several non-executive and director roles. He has also been the expert witness on several major fraud cases.
He joined the Board as a non-executive director in January 2020. Keith will chair the Trust’s audit and risk committee.
Dr Tim Peachey
Tim qualified as a doctor from Kings College Hospital School of Medicine in 1983. For nearly 20 years, he worked as a consultant anaesthetist at the Royal Free Hospital in London, specialising in pancreatic cancer surgery, liver surgery and liver transplantation. He also developed an interest in medical leadership and management and has held positions such as clinical director, divisional director and medical director at the Royal Free.
In 2012, Tim moved into full time management as chief executive of Barnet and Chase Farm Hospitals NHS Trust until its acquisition by the Royal Free. He then worked as the London associate medical director at the NHS Trust Development Authority before moving to Barts Health NHS Trust as improvement director and subsequently became deputy chief executive.
Tim now holds two NHS non-executive posts. In addition to his role at University Hospital Southampton, Tim also serves on the board for Isle of Wight NHS Trust as deputy chair. He is a practicing mediator specialising in the healthcare sector. He also consults for companies in the medical information technology industry.
Jenni is a former chief executive of Hampshire Police Authority and the office of the Hampshire Police and Crime Commissioner.
After beginning her career in the probation service, she was head hunted into the civil service, at the Home Office, where she spent four years before being becoming director of policy and research for the Independent Police Complaints Commission. In the latter role she was responsible for establishing governance of the new police complaints system.
She then spent two and a half years as a resident twinning adviser for the UK, based in Turkey to help set-up a law enforcement complaints system before taking up the role of chief executive of the county’s police authority. During her three years in the post, she supported the authority in developing effective governance processes to increase accountability and transparency while also helping the organisation deliver cost-savings whilst still improving performance and develop closer working relations with neighbouring forces.
In 2012, she became chief executive and monitoring officer for the Hampshire Police and Crime Commissioner, where she led the development of the office’s vision, mission, values and organisational strategy. She took on the role of investigating committee chair for the General Dental Council in 2014 and, in April that year, founded the Diversa Consultancy, which supports organisations with changes in business, culture and behaviour. She is also a member of the Judicial Conduct Investigating Office, a public appointment.
Professor Cyrus Cooper
Cyrus Cooper is professor of rheumatology and director of the MRC Lifecourse Epidemiology Unit. He's also vice-dean of the faculty of medicine at the University of Southampton and professor of epidemiology at the Nuffield Department of Orthopaedics (rheumatology and musculoskeletal sciences, University of Oxford).
He leads an internationally competitive programme of research into the epidemiology of musculoskeletal disorders, most notably osteoporosis. His key research contributions have been:
- discovery of the developmental influences which contribute to the risk of osteoporosis and hip fracture in late adulthood
- demonstration that maternal vitamin D insufficiency is associated with sub-optimal bone mineral accrual in childhood
- characterisation of the definition and incidence rates of vertebral fractures
- leadership of large pragmatic randomised controlled trials of calcium and vitamin D supplementation in the elderly as immediate preventative strategies against hip fracture.
He is president of the International Osteoporosis Foundation, chair of the BHF Project Grants Committee, an emeritus NIHR senior investigator, and associate editor of Osteoporosis International. He has previously served as chairman of the Scientific Advisors Committee (International Osteoporosis Foundation), the MRC Population Health Sciences Research Network and the National Osteoporosis Society of Great Britain. He has also been president of the Bone Research Society of Great Britain and has worked on numerous Department of Health, European Community and World Health Organisation committees and working groups.
Prof Cyrus has published extensively (over 900 research papers - hi=119) on osteoporosis and rheumatic disorders and pioneered clinical studies on the developmental origins of peak bone mass. In 2015, he was awarded an OBE for services to medical research.
In 1985, Jane joined the pharmaceutical company Glaxo as a management trainee, having graduated from London University with a degree in environmental science and pharmacology.
Here she rose to senior commercial vice president, gaining experience of a broad range of disease areas across different regions of the world. She specialised in leading global research and development teams in the formation of strategies to bring new medicines to patients. She also worked to ensure that the medicines developed were supported by robust evidence demonstrating their clinical and cost effectiveness. In delivering this she gained extensive experience of leading large diverse teams across a complex global organisation.
For five years, Jane ran her own strategy development consultancy, working across a breadth of healthcare organisations. In 2017 Jane gained an MSc in public health, with distinction, at King’s College, London University. Her studies focused on how to ensure the public are engaged in development of healthcare services and how social theories can help inform effective disease prevention and management. She is a director of Healthwatch Portsmouth.
Dave graduated in chemistry from the University of Southampton before entering management consulting, becoming a partner in Accenture’s strategy practice.
In 2003 he joined Exel Logistics (later bought by DHL), managing the company’s healthcare business across Europe and the Middle East. During this time, he established NHS Supply Chain, a UK organisation responsible for procuring and delivering medical consumables for the NHS in England, as well as sourcing capital equipment.
Dave joined the board of Cable & Wireless as sales director in 2008. He later set up his own strategy consulting practice serving the healthcare sector, completing numerous projects in the UK and the US.
Dave has also served as a non-executive director at The Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust between 2009 and 2016. He chaired the Trust’s quality committee.
Paula Head, chief executive
Paula joined the Trust as chief executive in September 2018, having been chief executive at the Royal Surrey County NHS Foundation Trust in Guildford and before that at Sussex Community NHS Foundation Trust.
She began her career as a pharmacist working in the community, hospitals and at health authorities before moving into general management and her first board position at Kingston Hospital. Since then she has spent time on the boards of commissioners and providers, including director of transformation at Frimley Park Hospital NHS FT.
Paula lives in Hampshire and has a daughter studying medicine at the University of Southampton.
Follow Paula on Twitter
David French, deputy CEO and chief financial officer
David joined the Trust in February 2016 as chief financial officer and served as interim chief executive from April to September 2018.
He read economics and social policy at the University of London before joining ICI plc, where he qualified as a chartered management accountant. David has extensive healthcare experience from the pharmaceutical industry, mostly Eli Lilly and Company where he held many commercial and financial roles in the UK and overseas.
He joined the NHS in 2010 as chief financial officer of Hampshire Hospitals NHS Foundation Trust. He also serves as a non-executive director for VIVID Housing Limited, a Hampshire-based social housing provider.
Joe Teape, chief operating officer
Joe joined the Trust as chief operating officer in December 2019. Previously he was deputy chief executive and director of operations of a large health board in Wales which managed integrated services across three counties including four district general hospitals as well as mental health, learning disability and community services.
Prior to this, Joe worked in director roles across finance and strategy within provider acute trusts acros the south west of England.
Joe is passionate about providing leadership and support for all staff, whatever their profession, and contributing to excellent patient care.
He is committed to open and ongoing engagement with the general public and often uses social media to engage with colleagues and with those who have an interest in healthcare.
Follow Joe on Twitter
Gail Byrne, director of nursing and organisational development
Gail joined the Trust in 2010 as deputy director of nursing and head of patient safety. Prior to this, she has worked at the Strategic Health Authority as head of patient safety, and director of clinical services at Portsmouth Hospital.
Gail has also worked in Brisbane, Australia as a hospital Macmillan nurse, and as general manager of a special purpose vehicle company for the private finance initiative at South Manchester Hospitals.
Follow Gail on Twitter
Dr Derek Sandeman, medical director
Derek was appointed to the Trust as a consultant physician in 1993 and went on to develop a regional endocrine service.
Throughout his career he has had extensive clinical leadership experience, most recently serving eight years as clinical director. Derek’s leadership roles have also included programme director for postgraduate education and the Wessex Endocrine Royal College representative.
He has a strong history of wider system engagement, working collaboratively with partners to improve systems resilience and pathways.
Jane Hayward, director of transformation
Jane joined the Trust in 2000 as clinical services manager for the cardiothoracic directorate after spending two years in Hertfordshire as director of performance and 11 years at Barts and the London Hospitals in various roles including planning, finance and commissioning.
Jane has led on human resources, information management and technology, improvement and modernisation and has been chief operating officer.
Jane joined the Trust Board in February 2008 and became director of transformation and improvement in January 2014.
Follow Jane on Twitter